Jan Aushadhi shops can replace branded drugs with generics

NEW DELHI: To promote low-cost generic medicines, the government’s top drug regulatory board has allowed Jan Aushadhi Kendras — which are like fair price shops for medicines under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana — to substitute doctor’s prescription with a generic brand.

On Thursday, the Drugs Technical Advisory Board cleared a proposal to amend a rule under the drugs law. “This proposal asking permission for chemists to substitute brands prescribed by doctors with other brands was pending for a very long time. For the time being, we have allowed only Jan Aushadhi stores to do so because we want to watch it on a trial basis,” an official said. So far, chemists were legally not allowed to replace the brand or the medicine prescribed by a doctor.

The official said allowing all retailers to substitute medicine brands may open up the market to corruption as chemists may push brands with higher margin. The move is also likely to promote Jan Aushadhi stores which have failed to take off as well as intended in the last few years. At present, there are over 4,000 Jan Aushadhi stores.

  • Related Posts

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Eli Lilly working on single-dose drug to be administered via IV for long-term gain Mumbai: For millions of heart patients struggling with elevated levels of cholesterol, there is a ray…

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Regeneron Pharmaceuticals, Inc. has announced plans to establish the Regeneron Global Capability Centre (GCC) in Hyderabad, a strategic investment that deepens its global operations and scales business functions to advance…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    STF busts fake meds racket spread across 6 states

    STF busts fake meds racket spread across 6 states